日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy

药代动力学分析将免疫球蛋白暴露量与慢性炎症性脱髓鞘性多发性神经病的临床疗效联系起来

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.12647
Tortorici, Michael A; Yuraszeck, Theresa; Cornblath, David; Bril, Vera; Hartung, Hans-Peter; Sobue, Gen; Lewis, Richard A; Merkies, Ingemar S J; Lawo, John-Philip; Praus, Michaela; Durn, Billie L; Mielke, Orell; Ma, Xuewen; Jauslin, Petra; Pfister, Marc; van Schaik, Ivo N
炎症/感染
炎症
神经科学
免疫/内分泌
发表日期：2021
文献求助 收藏

Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review

慢性炎症性脱髓鞘性多发性神经病中的安慰剂效应：PATH 研究和系统评价

期刊:Journal of the Peripheral Nervous System
影响因子:3.2
doi:10.1111/jns.12402
Lewis, Richard A; Cornblath, David R; Hartung, Hans-Peter; Sobue, Gens; Lawo, John-Philip; Mielke, Orell; Durn, Billie L; Bril, Vera; Merkies, Ingemar S J; Bassett, Paul; Cleasby, Alexa; van Schaik, Ivo N
炎症/感染
炎症
神经科学
发表日期：2020
文献求助 收藏

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study

皮下注射免疫球蛋白IgPro20治疗CIDP的长期安全性和有效性：PATH扩展研究

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000000590
van Schaik, Ivo N; Mielke, Orell; Bril, Vera; van Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Durn, Billie L; Cornblath, David R; Merkies, Ingemar S J
免疫/内分泌
发表日期：2019
文献求助 收藏

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study

慢性炎症性脱髓鞘性多发性神经病患者停用静脉注射免疫球蛋白后的稳定治疗：Hizentra治疗多发性神经病研究的随机分组前阶段结果

期刊:Journal of the Peripheral Nervous System
影响因子:3.2
doi:10.1111/jns.12303
Mielke, Orell; Bril, Vera; Cornblath, David R; Lawo, John-Philip; van Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A; Merkies, Ingemar S J; Sobue, Gen; Durn, Billie; Shebl, Amgad; van Schaik, Ivo N
炎症/感染
炎症
神经科学
免疫/内分泌
发表日期：2019
文献求助 收藏

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

静脉注射免疫球蛋白治疗慢性炎症性脱髓鞘性多发性神经病（CIDP）的疗效和安全性：PRIMA 和 PATH 研究的合并数据

期刊:Journal of the Peripheral Nervous System
影响因子:3.2
doi:10.1111/jns.12302
Merkies, Ingemar S J; van Schaik, Ivo N; Léger, Jean-Marc; Bril, Vera; van Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A; Sobue, Gen; Lawo, John-Philip; Durn, Billie L; Cornblath, David R; De Bleecker, Jan L; Sommer, Claudia; Robberecht, Wim; Saarela, Mika; Kamienowski, Jerzy; Stelmasiak, Zbigniew; Tackenberg, Björn; Mielke, Orell
炎症/感染
炎症
神经科学
免疫/内分泌
发表日期：2019
文献求助 收藏

Safety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials

四因子凝血酶原复合物浓缩剂与血浆在维生素K拮抗剂逆转中的安全性比较：两项IIIb期临床试验的综合分析

期刊:Academic Emergency Medicine
影响因子:3.2
doi:10.1111/acem.12911
Milling, Truman J Jr; Refaai, Majed A; Sarode, Ravi; Lewis, Brandon; Mangione, Antoinette; Durn, Billie L; Harman, Amy; Lee, Martin L; Goldstein, Joshua N
发表日期：2016
文献求助 收藏

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study

一项随机、血浆对照的IIIb期研究评估了4因子凝血酶原复合物浓缩剂在服用维生素K拮抗剂并出现大出血患者中的疗效和安全性。

期刊:Circulation
影响因子:38.6
doi:10.1161/CIRCULATIONAHA.113.002283
Sarode, Ravi; Milling, Truman J Jr; Refaai, Majed A; Mangione, Antoinette; Schneider, Astrid; Durn, Billie L; Goldstein, Joshua N
发表日期：2013
文献求助 收藏